Summary of DYNAVAX TECHNOLOGIES CORP

Quotes & Info

Enter Symbol(s):
e.g. YHOO, ^DJI

Symbol Lookup | Financial Search

DVAX > SEC Filings for DVAX > Form 8-K on 12-Aug-2009

All Recent SEC Filings

Show all filings for DYNAVAX TECHNOLOGIES CORP | Request a Trial to NEW EDGAR Online Pro

Form 8-K for DYNAVAX TECHNOLOGIES CORP

12-Aug-2009

Other Events, Financial Statements and Exhibits

Item 8.01. Other Events

On August 12, 2009, Dynavax Technologies Corporation (Dynavax) issued a press release titled "Dynavax Announces European Development Strategy for HEPLISAV(TM) Hepatitis B Vaccine." A copy of the press release is attached as Exhibit 99.1 to this current report and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits

(d) Exhibit

Exhibit No.    Description

99.1        Press Release, dated August 12, 2009, titled "Dynavax Announces

European Development Strategy for HEPLISAV(TM) Hepatitis B Vaccine."

Add DVAX to Portfolio

Set Alert

Email to a Friend

Get SEC Filings for Another Symbol: Symbol Lookup

Quotes & Info for DVAX - All Recent SEC Filings

Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial Sign Up Now

Copyright © 2010 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.